EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KDM1A regulates nephron progenitor programs and is associated with human kidney disease risk

Lakshmi P Kolligundla iD, Dhanunjay Mukhi, Jonathan Levinsohn, Andi Bergerson, Yanjuan Hou, Hongbo Liu, Brain C Capell, Katalin Susztak

Nephrology Dialysis Transplantation · 30.10.2026 · 41 (11) · 2027-2041

DOI: 10.1093/ndt/gfag073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 01.05.2026. Verfasst von Lakshmi P Kolligundla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Renal, Electrolyte, and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Histone Demethylases, Stem Cells, Nephrons, Kidney Diseases. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Genome-wide association studies (GWAS) have identified numerous loci associated with kidney function, but linking non-coding variants to causal effector genes remains challenging. By integrating fine-mapped GWAS data from 2.27 million individuals with kidney expression and epigenomic datasets, we identified KDM1A as a top-prioritized gene at a kidney function locus. KDM1A is broadly expressed across nephron segments in mouse and human kidneys and is consistently upregulated in chronic kidney disease (CKD).

Methods

We generated lineage-specific Kdm1a knockout mice targeting nephron progenitors (Six2-Cre) or differentiated tubular epithelial cells (Cdh16/Ksp1-Cre). Renal structure and function were assessed at baseline and following adenine-induced injury or unilateral ureteral obstruction using histology, immunoblotting, and gene expression analyses. Pharmacologic inhibition of KDM1A was evaluated in embryonic kidney explant cultures.

Results

Nephron progenitor-specific deletion of Kdm1a resulted in severe developmental defects, including nephron loss, cystic degeneration, tubular atrophy, and early interstitial fibrosis. Mutant kidneys exhibited suppression of progenitor and segment-specific epithelial programs, loss of solute transporter expression, and derepression of developmental signaling pathways, including Notch and Wnt, accompanied by apoptosis and inflammation. In contrast, deletion of Kdm1a in differentiated tubular epithelial cells preserved baseline renal structure and function and did not modify fibrotic responses to injury. Pharmacologic inhibition of KDM1A during kidney development phenocopied genetic loss and led to accumulation of H3K4 methylation.

Conclusions

KDM1A is a genetically supported, developmentally essential chromatin regulator required for nephron differentiation but dispensable in differentiated tubular epithelium. Its reactivation in CKD highlights a context-dependent epigenetic role and cautions against nonspecific KDM1A inhibition..

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone DemethylasesStem CellsNephronsKidney DiseasesAnimalsHumansMiceMice, KnockoutGenome-Wide Association StudyCell Differentiation

Stichwörter der Autor:innen

GWASNotch signalingchronic kidney diseasefibrosisnephron progenitor differentiation

Substanzen

Histone DemethylasesKDM1a protein, mouseKDM1A protein, human

Autor:innen und Institutionen

  • Renal, Electrolyte, and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Penn/CHOP Kidney Innovation Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

ORCID-Profile: Lakshmi P Kolligundla

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Kolligundla, L. P., Mukhi, D., Levinsohn, J., Bergerson, A., Hou, Y., Liu, H., Capell, B. C., & Susztak, K. (2026). KDM1A regulates nephron progenitor programs and is associated with human kidney disease risk. Nephrology Dialysis Transplantation, 41(11), 2027-2041. https://doi.org/10.1093/ndt/gfag073

Vancouver

Kolligundla LP, Mukhi D, Levinsohn J, Bergerson A, Hou Y, Liu H, et al. KDM1A regulates nephron progenitor programs and is associated with human kidney disease risk. Nephrology Dialysis Transplantation. 2026;41(11):2027-2041. doi:10.1093/ndt/gfag073

BibTeX
@article{Kolligundla2026,
  author = {Kolligundla, Lakshmi P and Mukhi, Dhanunjay and Levinsohn, Jonathan and Bergerson, Andi and Hou, Yanjuan and Liu, Hongbo and Capell, Brain C and Susztak, Katalin},
  title = {KDM1A regulates nephron progenitor programs and is associated with human kidney disease risk},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  volume = {41},
  number = {11},
  pages = {2027--2041},
  doi = {10.1093/ndt/gfag073}
}
Kostenlos starten →